MetaCap

Johnson & Johnson Insider Trades

NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD

261.44+4.96 (+1.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
25 · $127.04M
Shares bought / sold
0 / 503.02K
Net activity
Net selling $127.0 million

Johnson & Johnson insider activity

Over the last 12 months, Johnson & Johnson insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 25 sales. Insiders bought $0 and sold $127.0 million worth of stock, for net insider selling of $127.0 million. The largest seller was Duato Joaquin, with $44.7 million in reported sales.

The most recent filing shows Schmid Timothy (EVP, WW Chair, MedTech) reporting a transaction in 11,070 shares at $131.94 on Sep 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put JNJ's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

JNJ insider transactions

Johnson & Johnson insider transactions
DateInsiderTypeSharesValueFiling
Sep 2, 2026Schmid TimothyEVP, WW Chair, MedTechSale22,527$6.19MForm 4
Sep 2, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise22,527$3.41MForm 4
Sep 2, 2026Schmid TimothyEVP, WW Chair, MedTechSale11,070$3.04MForm 4
Sep 2, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise11,070$1.46MForm 4
Aug 17, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineSale15,000$3.95MForm 4
Aug 17, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineOption exercise15,000$1.74MForm 4
Aug 13, 2026Duato JoaquinCEO and Chairman of the BoardSale102,315$26.70MForm 4
Aug 13, 2026Duato JoaquinCEO and Chairman of the BoardSale20,976$5.50MForm 4
Aug 13, 2026Duato JoaquinCEO and Chairman of the BoardOption exercise123,291$14.26MForm 4
Aug 6, 2026Forminard ElizabethEVP, Chief Legal OfficerSale6,574$1.68MForm 4
Aug 6, 2026Forminard ElizabethEVP, Chief Legal OfficerSale9,344$2.41MForm 4
Aug 6, 2026Forminard ElizabethEVP, Chief Legal OfficerOption exercise9,344$1.23MForm 4
Aug 5, 2026Duato JoaquinCEO and Chairman of the BoardSale6,523$1.69MForm 4
Aug 5, 2026Duato JoaquinCEO and Chairman of the BoardSale41,957$10.83MForm 4
Jul 20, 2026Broadhurst VanessaEVP, Global Corp AffairsSale23,054$5.79MForm 4
Jul 20, 2026Broadhurst VanessaEVP, Global Corp AffairsOption exercise11,925$1.57MForm 4
Jul 20, 2026Broadhurst VanessaEVP, Global Corp AffairsOption exercise11,129$1.44MForm 4
Jun 11, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerSale10,000$2.41MForm 4
Jun 11, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerOption exercise10,000$1.16MForm 4
May 1, 2026REED JOHN CEVP, Innovative Medicine, R&DTax withholding11,002$2.53MForm 4
May 1, 2026REED JOHN CEVP, Innovative Medicine, R&DOption exercise25,255—Form 4
Feb 27, 2026Decker Robert JVP Corporate ControllerSale4,075$1.01MForm 4
Feb 27, 2026Decker Robert JVP Corporate ControllerOption exercise4,075$471.36KForm 4
Feb 20, 2026Schmid TimothyEVP, WW Chair, MedTechSale1,322$324.76KForm 4
Feb 18, 2026Schmid TimothyEVP, WW Chair, MedTechSale8,998$2.20MForm 4
Feb 18, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise8,998$1.17MForm 4
Feb 18, 2026Schmid TimothyEVP, WW Chair, MedTechSale13,625$3.33MForm 4
Feb 18, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise13,625$1.58MForm 4
Feb 17, 2026REED JOHN CEVP, Innovative Medicine, R&DSale2,283$554.77KForm 4
Feb 17, 2026REED JOHN CEVP, Innovative Medicine, R&DSale29,927$7.27MForm 4
Feb 17, 2026REED JOHN CEVP, Innovative Medicine, R&DOption exercise29,927$4.67MForm 4
Feb 17, 2026REED JOHN CEVP, Innovative Medicine, R&DSale21,721$5.28MForm 4
Feb 17, 2026REED JOHN CEVP, Innovative Medicine, R&DOption exercise21,721$3.43MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOSale24,961$6.06MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOSale33,386$8.10MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOOption exercise33,386$4.40MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOSale12,066$2.93MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOOption exercise12,066$1.56MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOSale19,241$4.68MForm 4
Feb 17, 2026Wolk Joseph JExec VP, CFOOption exercise19,241$2.23MForm 4
Feb 17, 2026Swanson James D.EVP, CIOSale20,521$4.98MForm 4
Feb 17, 2026Swanson James D.EVP, CIOOption exercise20,521$3.38MForm 4
Feb 15, 2026Schmid TimothyEVP, WW Chair, MedTechTax withholding448$109.07KForm 4
Feb 15, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise1,026—Form 4
Feb 15, 2026Schmid TimothyEVP, WW Chair, MedTechTax withholding15$3.65KForm 4
Feb 15, 2026Schmid TimothyEVP, WW Chair, MedTechOption exercise1,028—Form 4
Feb 15, 2026Duato JoaquinCEO and Chairman of the BoardTax withholding1,960$477.16KForm 4
Feb 15, 2026Duato JoaquinCEO and Chairman of the BoardOption exercise4,505—Form 4
Feb 15, 2026Duato JoaquinCEO and Chairman of the BoardTax withholding1,602$390.01KForm 4
Feb 15, 2026Duato JoaquinCEO and Chairman of the BoardOption exercise3,682—Form 4
Feb 15, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineTax withholding945$230.06KForm 4
Feb 15, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineOption exercise1,847—Form 4
Feb 15, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineTax withholding816$198.66KForm 4
Feb 15, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineOption exercise1,594—Form 4
Feb 15, 2026Forminard ElizabethEVP, Chief Legal OfficerTax withholding544$132.44KForm 4
Feb 15, 2026Forminard ElizabethEVP, Chief Legal OfficerOption exercise1,063—Form 4
Feb 15, 2026Forminard ElizabethEVP, Chief Legal OfficerTax withholding492$119.78KForm 4
Feb 15, 2026Forminard ElizabethEVP, Chief Legal OfficerOption exercise961—Form 4
Feb 15, 2026REED JOHN CEVP, Innovative Medicine, R&DTax withholding528$128.54KForm 4
Feb 15, 2026REED JOHN CEVP, Innovative Medicine, R&DOption exercise1,847—Form 4
Feb 15, 2026REED JOHN CEVP, Innovative Medicine, R&DTax withholding385$93.73KForm 4
Feb 15, 2026REED JOHN CEVP, Innovative Medicine, R&DOption exercise1,349—Form 4
Feb 15, 2026Wolk Joseph JExec VP, CFOTax withholding817$198.90KForm 4
Feb 15, 2026Wolk Joseph JExec VP, CFOOption exercise1,878—Form 4
Feb 15, 2026Wolk Joseph JExec VP, CFOTax withholding858$208.88KForm 4
Feb 15, 2026Wolk Joseph JExec VP, CFOOption exercise1,971—Form 4
Feb 15, 2026Decker Robert JVP Corporate ControllerTax withholding95$23.13KForm 4
Feb 15, 2026Decker Robert JVP Corporate ControllerOption exercise344—Form 4
Feb 15, 2026Decker Robert JVP Corporate ControllerTax withholding94$22.88KForm 4
Feb 15, 2026Decker Robert JVP Corporate ControllerOption exercise339—Form 4
Feb 15, 2026Mulholland KristenEVP, Chief HR OfficerTax withholding251$61.11KForm 4
Feb 15, 2026Mulholland KristenEVP, Chief HR OfficerOption exercise575—Form 4
Feb 15, 2026Mulholland KristenEVP, Chief HR OfficerTax withholding172$41.87KForm 4
Feb 15, 2026Mulholland KristenEVP, Chief HR OfficerOption exercise419—Form 4
Feb 15, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerTax withholding325$79.12KForm 4
Feb 15, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerOption exercise635—Form 4
Feb 15, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerTax withholding310$75.47KForm 4
Feb 15, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerOption exercise606—Form 4
Feb 15, 2026Swanson James D.EVP, CIOTax withholding309$75.23KForm 4
Feb 15, 2026Swanson James D.EVP, CIOOption exercise709—Form 4
Feb 15, 2026Swanson James D.EVP, CIOTax withholding214$52.10KForm 4
Feb 15, 2026Swanson James D.EVP, CIOOption exercise492—Form 4
Feb 13, 2026Decker Robert JVP Corporate ControllerTax withholding104$25.43KForm 4
Feb 13, 2026Decker Robert JVP Corporate ControllerOption exercise312—Form 4
Feb 13, 2026Mulholland KristenEVP, Chief HR OfficerTax withholding1,027$251.15KForm 4
Feb 13, 2026Mulholland KristenEVP, Chief HR OfficerOption exercise3,602—Form 4
Feb 13, 2026Mulholland KristenEVP, Chief HR OfficerTax withholding135$33.01KForm 4
Feb 13, 2026Mulholland KristenEVP, Chief HR OfficerOption exercise410—Form 4
Feb 13, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerTax withholding6,414$1.57MForm 4
Feb 13, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerOption exercise13,706—Form 4
Feb 13, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerTax withholding217$53.07KForm 4
Feb 13, 2026Wengel Kathryn EEVP, Chief TO and Risk OfficerOption exercise651—Form 4
Feb 13, 2026Swanson James D.EVP, CIOSale22,191$5.41MForm 4
Feb 13, 2026Swanson James D.EVP, CIOOption exercise22,191$3.61MForm 4
Feb 13, 2026Swanson James D.EVP, CIOSale19,368$4.72MForm 4
Feb 13, 2026Swanson James D.EVP, CIOOption exercise19,368$3.21MForm 4
Feb 13, 2026Swanson James D.EVP, CIOTax withholding3,547$867.42KForm 4
Feb 13, 2026Swanson James D.EVP, CIOOption exercise9,412—Form 4
Feb 13, 2026Swanson James D.EVP, CIOTax withholding143$34.97KForm 4
Feb 13, 2026Swanson James D.EVP, CIOOption exercise447—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related